LanzaTech Global, Inc. Files 8-K: Director/Officer Changes & More
Ticker: LNZAW · Form: 8-K · Filed: Jan 22, 2025 · CIK: 1843724
| Field | Detail |
|---|---|
| Company | Lanzatech Global, INC. (LNZAW) |
| Form Type | 8-K |
| Filed Date | Jan 22, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance, filing
TL;DR
LanzaTech 8-K dropped: Director/officer changes, compensation details, and other events filed Jan 22.
AI Summary
LanzaTech Global, Inc. filed an 8-K on January 22, 2025, reporting events as of January 21, 2025. The filing includes information regarding the departure and election of directors, appointment of officers, and compensatory arrangements. It also covers other events and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in LanzaTech's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with details on compensatory arrangements, can signal internal shifts that may affect company strategy and performance.
Key Players & Entities
- LanzaTech Global, Inc. (company) — Registrant
- AMCI Acquisition Corp. II (company) — Former Company Name
- January 21, 2025 (date) — Date of earliest event reported
- January 22, 2025 (date) — Filing Date
FAQ
What specific changes were made regarding directors or officers?
The filing indicates the departure of directors or certain officers and the election of directors and appointment of certain officers.
What is the significance of the 'Compensatory Arrangements of Certain Officers' section?
This section details the compensation plans and arrangements for key executives within LanzaTech Global, Inc.
What other events are reported in this 8-K filing?
The filing also reports on 'Other Events' which are not specifically detailed in the provided header information but are part of the official report.
When was LanzaTech Global, Inc. formerly known as?
LanzaTech Global, Inc. was formerly known as AMCI Acquisition Corp. II, with a name change date of February 1, 2021.
What is the principal executive office address for LanzaTech Global, Inc.?
The principal executive office is located at 8045 Lamon Avenue, Suite 400, Skokie, Illinois 60077.
Filing Stats: 772 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-01-21 20:53:45
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share LNZA The Nasdaq Stock Market
- $11.50 — of Common Stock at an exercise price of $11.50 LNZAW The Nasdaq Stock Market LLC Ind
Filing Documents
- amci-20250121.htm (8-K) — 32KB
- lnzapressrelease-jan2120.htm (EX-99.1) — 13KB
- lanzaxinvestorpresentati.htm (EX-99.2) — 13KB
- lanzaxinvestorpresentati001.jpg (GRAPHIC) — 103KB
- lanzaxinvestorpresentati002.jpg (GRAPHIC) — 290KB
- lanzaxinvestorpresentati003.jpg (GRAPHIC) — 177KB
- lanzaxinvestorpresentati004.jpg (GRAPHIC) — 151KB
- lanzaxinvestorpresentati005.jpg (GRAPHIC) — 114KB
- lanzaxinvestorpresentati006.jpg (GRAPHIC) — 139KB
- lanzaxinvestorpresentati007.jpg (GRAPHIC) — 110KB
- lanzaxinvestorpresentati008.jpg (GRAPHIC) — 164KB
- lanzaxinvestorpresentati009.jpg (GRAPHIC) — 132KB
- lanzaxinvestorpresentati010.jpg (GRAPHIC) — 154KB
- lnzapressrelease-jan2120001.jpg (GRAPHIC) — 240KB
- lnzapressrelease-jan2120002.jpg (GRAPHIC) — 253KB
- lnzapressrelease-jan2120003.jpg (GRAPHIC) — 228KB
- lnzapressrelease-jan2120004.jpg (GRAPHIC) — 212KB
- lnzapressrelease-jan2120005.jpg (GRAPHIC) — 23KB
- 0001628280-25-002081.txt ( ) — 3672KB
- amci-20250121.xsd (EX-101.SCH) — 2KB
- amci-20250121_def.xml (EX-101.DEF) — 17KB
- amci-20250121_lab.xml (EX-101.LAB) — 29KB
- amci-20250121_pre.xml (EX-101.PRE) — 17KB
- amci-20250121_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On January 21, 2025, the Company issued a press release announcing its planned formation of LanzaX, a newly named business unit dedicated to its wholly owned synthetic biology platform, which the Company intends to spin out from its core biorefining business. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release announcing planned formation of LanzaX dated January 21, 2025. 99.2 Presentation on LanzaX dated January 21, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 21, 2025 LANZATECH GLOBAL, INC. By: /s/ Joseph Blasko Name: Joseph Blasko Title: General Counsel and Corporate Secretary 3